Background {#Sec1}
==========

Evidence has accumulated that oxidative stress may be implicated in the etiology of atherosclerosis. The risk of developing atherosclerosis is determined by the absolute levels of atherogenic lipoproteins, and by the relative tendency of such substances to undergo oxidation \[[@CR1]\]. Specifically, low-density lipoproteins-cholesterol (LDL-C) are highly susceptible to oxidative processes initiated by oxygen free radicals, whereby oxidatively-modified LDL-C particles (ox-LDL) are produced as a result \[[@CR2]\].

The arterial intima is the first site where oxidative modification of LDL-C occurs \[[@CR2]\]. In fact, Ox-LDL particles constitute one of the major ligands for scavenger receptors on the arterial macrophage, which could account for foam cell formation \[[@CR2]\]. Ox-LDL are strongly atherogenic and immunogenic \[[@CR2], [@CR3]\]. Consequently, autoantibodies against ox-LDL (ox-LDL-Ab) are produced by the immune system \[[@CR2]\]. In vivo, elevated titers of ox-LDL-Ab have been found in many diseases such as atherosclerosis and coronary heart disease \[[@CR3]\], hypertension \[[@CR4]\], renal failure \[[@CR5]\], and diabetes \[[@CR6]\].

Physical activity is associated with beneficial changes in circulating lipids and lipoproteins \[[@CR7], [@CR8]\], body weight, blood pressure, insulin sensitivity \[[@CR9]\], and coagulation parameters \[[@CR10], [@CR11]\]. Additionally, current data support that heavy endurance exercise increases the rate of oxygen consumption in humans up to 20-fold inducing reactive oxygen species (ROS) formation, and the removal of these formed species depends on antioxidant systems \[[@CR12]\]. However, if the rise in the level of ROS exceeds the antioxidant capacity to neutralize them, as observed during strenuous aerobic exercise \[[@CR13]--[@CR15]\], or if antioxidant defenses are severely hampered, then cell lipids, proteins, and even DNA material may suffer oxidative damage \[[@CR16]\]. Therefore, there may be an apparent paradox between the benefits of heavy aerobic exercise on cardiovascular risk factors and the potentially deleterious consequences of free radicals generated during intense aerobic exercise.

In this regard, professional athletes may be exposed to atherogenic and cardiovascular risks as it has already been suggested \[[@CR17], [@CR18]\]. In the present study, we determined the titers of ox-LDL-Ab in a group of professional soccer athletes playing in Cameroon, a Sub-Saharan African (SSA) country, and evaluated their evolution during part of a competition season as well as the antioxidant status to find out if this latter correlates with the immune response to oxidative modification of LDL-C.

Methods {#Sec2}
=======

Participants and setting {#Sec3}
------------------------

The procedures used in the present study are extensively described elsewhere \[[@CR19]\]. We conducted a prospective and descriptive cohort study from May to July 2012 among a team of the Cameroon Elite one Football Championship, namely "Renaissance of Ngoumou". This is a soccer club founded in 2000 and based in Ngoumou, a town situated 60 km from Yaoundé, the capital city of Cameroon.

Participants were male soccer players belonging to the just-cited team, enrolled if they were in good health and irrespective of their age, body mass index, region of origin and current diet. Before commencing the Championship in early March 2012, these players went through 14 weeks of intensive physical preparation consisting of at least 2 h of daily trainings plus regular friendly matches. Our study period covered the first leg of the Elite One Championship, part of the return phase, and a truce during which the team was engaged in qualification matches counting for the Cameroon Male Soccer National Cup. During this period, players were weekly subjected to 10 h of workout plus a match. Before enrolling a player in the study, we obtained a written and signed informed consent.

Blood sampling {#Sec4}
--------------

Three samplings were performed during the study period, occurring at an 8-week constant interval: March (T1), May (T2), and July 2012 (T3). The players had to be free of any training for at least 24 h prior to the blood collection, this being effectuated early in the morning after a 12-h overnight fasting. Blood was aseptically collected from each participant by venipuncture of the brachial vein in a 5 ml EDTA tube and in a 5 ml dry tube, without a tourniquet or fist clenching. Subsequently, samples were put on ice and immediately transported to the biochemistry laboratory where plasma and serum specimens were separated by centrifugation at 3000 rpm within 5 min and kept at −20 °C for further biochemical analyses not later than a week after sampling.

Biochemical measurements {#Sec5}
------------------------

Each and every biochemical assay was performed at each sampling. Players' lipid profile was measured in the serum using a spectrophotometer (Spectrophotometer 722--2000, MAIKONG Industry Co., Ltd., Shenzhen, China). Standard colorimetric methods served for the measurement of total cholesterol, triglycerides (TG) and high-density lipoproteins-cholesterol (HDL-C), with reagents from CYPRESS Diagnostics (CYPRESS Diagnostics, Langdorp, Belgium). LDL-C was derived based on the Friedwald formula.

Titers of ox-LDL-Ab were determined using commercial enzyme linked immunosurbant assay (ELISA) kits from Cusabio Biotech^®^ (Cusabio Biotech Company, Hubei, China), and were expressed in mIU/ml. A microplate reader (Reader IRE 96, SFRI Medical Diagnostics, Saint Jean d'Illac, France) served for the purpose. Normal values of Ox-LDL-Ab ranged between 200 and 600 mIU/ml in accordance with Pincemail et al. \[[@CR17]\]. In order to evaluate the players' anti-oxidant defense mechanisms, we measured the activity of superoxide dismutase (SOD) as well as the levels of uric acid, reduced glutathione (GSH) and that of the ferric reducing anti-oxidant power (FRAP). The procedures used for these assays were fully presented in a previous report \[[@CR19]\]. The reading was performed on a spectrophotometer (Spectrophotometer 722--2000, MAIKONG Industry Co., Ltd., Shenzhen, China).

Statistical methods {#Sec6}
-------------------

Statistical analyses were conducted using SPSS software (version 20.0, IBM SPSS^®^ Statistics, Chicago, Illinois, USA) and the R statistical package version 3.2.2 (The R Foundation for Statistical Computing, Vienna, Austria). Results are presented as count (proportion) and median (inter quartile range, IQR) where appropriate. The normality was tested, which was not effective; consequently, non-parametric tests were used. The Wilcoxon test served for the 2-paired sample comparisons, and the Friedman test was used to perform the overall trends analysis. The Spearman correlation test was utilized to seek for any association between quantitative variables.

The regression analysis was run using the mixed linear regression model. The initial model was as follows: $$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} {\text{Ox-LDL-Ab}} &= {\text{b}}_{0} + {\text{b}}_{ 1} *\;{\text{visit}} + {\text{b}}_{ 2} *\;{\text{uric-acid}} + {\text{b}}_{ 3} *\;{\text{HDL}} + {\text{b}}_{ 4} *\;{\text{LDL}} \\ &\quad + {\text{b}}_{ 5} *\;{\text{triglycerides}} + \,{\text{b}}_{ 6} *\;{\text{FRAP}} +\, {\text{b}}_{ 7} *\;{\text{GSH}} \\ &\quad + {\text{b}}_{ 8} *\;{\text{SOD}} + {\text{b}}_{ 9} *\;{\text{age}} + {\text{b}}_{ 10} *\;\,{\text{BMI}} \\ &\quad + {\text{b}}_{ 1 1} *\;{\text{total cholesterol}} + {\text{b}}_{0 1} + {\text{b}}_{0 2} *\;{\text{visit}} \hfill \\ \end{aligned},$$\end{document}$$where b~1~--b~11~ were the coefficients of the fixed effects of the explanatory variables, and b~01~ and b~02~ were the coefficients of the random effects, respectively the random intercept and the random slope. Estimation of the model parameters was done using the restricted maximum likelihood method. Based on the analysis of variance (ANOVA) test, we ended up with the model containing the random slope and intercept and with the smallest akaike information criterion (AIC) when taking into account the correlation structure of random effects \[Autoregressive (1)\], ANOVA being insignificant when performing a 2-by-2 comparison of the models. Results were considered statistically significant each time the *p* value was less than 0.05.

Ethical considerations {#Sec7}
----------------------

This study was granted an ethical clearance before initiation, delivered by the Cameroon National Ethics Committee for Human Health Research (No. 081/CNE/SE/2012). Additionally, we received approvals from the administrative staff of the team and from the Cameroon Football Federation. All procedures used in this survey were in keeping with the current revision of the Helsinki Declaration. On the other hand, all aspects and procedures of the study were fully presented and explained to each potential participant; we included only those who volunteered to take part in the study, who signed an informed consent accordingly. They were free to abandon the study at any moment without any prejudice.

Results {#Sec8}
=======

Of the 30 players present at the first sampling, only 18 players attended the last measurement, hence a 40% proportion of abandon. Ages of participants ranged from 16 to 28 years with a median of 19.5 (19--23) years. The BMI varied between 21.4 and 25.8 kg/m^2^ with a median equal to 23.3 (22.4--24.4) kg/m^2^ (Table [1](#Tab1){ref-type="table"}). Two subjects (11.1%) were slightly overweight (25 \< BMI \< 26 kg/m^2^).Table 1Overall results of the study participants at each measurement (N = 18)VariableMinMaxMeanSDMedianIQRAge (years)162820.63.119.519--23BMI (kg/m^2^)21.425.823.41.323.322.4--24.4Total cholesterol 1 (mg/dl)8718613522136123--145Total cholesterol 2 (mg/dl)12519315618155142--169Total cholesterol 3 (mg/dl)11820316123161145--177Triglycerides 1 (mg/dl)6113884217669--99Triglycerides 2 (mg/dl)5911481177969--91Triglycerides 3 (mg/dl)6812796199383--116HDL-C 1 (mg/dl)358563136451--72HDL-C 2 (mg/dl)539066116555--72HDL-C 3 (mg/dl)408158115849--63LDL-C 1 (mg/dl)2010156205541--69LDL-C 2 (mg/dl)3810474197956--87LDL-C 3 (mg/dl)5013482218170--96ox-LDL-Ab1 (mIU/ml)379.521786.20724.69366.65653.32468.18--838.80ox-LDL-Ab2 (mIU/ml)197.521494.34832.10377.54777.73553.71--1150.74ox-LDL-Ab3 (mIU/ml)284.782640.761198.67564.051037.68901.74--1481.46Uric acid 1 (mg/l)32.45115.4761.6720.0558.1149.05--70.00Uric acid 2 (mg/l)26.4663.3848.449.5848.5141.98--54.27Uric acid 3 (mg/l)42.8486.8157.5410.8756.7448.39--63.97FRAP 1 (mmol/l)0.4050.6580.5390.0820.5370.469--0.613FRAP 2 (mmol/l)0.2850.5970.4410.0840.4510.397--0.488FRAP 3 (mmol/l)0.2040.6160.4700.1260.5030.363--0.575GSH 1 (µmol/l)1.207.353.711.613.082.61--4.83GSH 2 (µmol/l)1.396.613.381.403.052.44--4.39GSH 3 (µmol/l)1.987.943.841.423.642.72--4.46SOD 1 (IU/ml)4.9526.4515.356.7017.258.27--20.99SOD 2 (IU/ml)5.6326.4514.236.6214.387.60--20.11SOD 3 (IU/ml)4.4429.9018.058.5721.256.88--24.44*Min* minimum, *Max* maximum, *SD* standard deviation, *IQR* inter quartile range, *BMI* body mass index

The median levels of total cholesterol, HDL-C, LDL-C and TG were both normal throughout the three samplings (Table [1](#Tab1){ref-type="table"}). Total cholesterol and LDL-C significantly increased from T1 to T3: median 136 vs. 161 mg/dl; p = 0.003 and 55 vs. 81 mg/dl; p = 0.006, respectively. Contrariwise, TG and HDL-C titers did not vary significantly throughout the 3 measurements: p = 0.061 and p = 0.192 respectively (Tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"}).Table 2Comparison of variables between the 3 measurements (T1, T2 and T3)Comparisonp value^a^Overall comparison (p value)^b^Total cholesterol 1--total cholesterol 2*0.006*\*Total cholesterol 2--total cholesterol 30.257*0.003*\*Total cholesterol 1--total cholesterol 3*0.004*\*Triglycerides 1--triglycerides 20.794Triglycerides 2--triglycerides 3*0.018*\*0.061Triglycerides 1--triglycerides 30.094HDL-C 1--HDL-C 20.381HDL-C 2--HDL-C 30.0890.192HDL-C 1--HDL-C 30.107LDL-C 1--LDL-C 2*0.008*\*LDL-C 2--LDL-C 30.064*0.006*\*LDL-C 1--LDL-C 3*0.002*\*ox-LDL-Ab 1--ox-LDL-Ab 20.122ox-LDL-Ab 2--ox-LDL-Ab 3*0.010*\**0.006*\*ox-LDL-Ab 1--ox-LDL-Ab 3*0.006*\*Uric acid 1--uric acid 2*0.001*\*Uric acid 2--uric acid 3*0.002*\**0.001*\*Uric acid 1--uric acid 30.557FRAP 1--FRAP 2*0.004*\*FRAP 2--FRAP 30.528*0.003*\*FRAP 1--FRAP 3*0.035*\*GSH 1--GSH 20.663GSH 2--GSH 30.2060.115GSH 1--GSH 30.306SOD 1--SOD 20.170SOD 2--SOD 3*0.007*\*0.110SOD 1--SOD 30.065\* p value \<0.05^a^These 2-paired comparisons were performed using the Wilcoxon test^b^These are the results of overall comparisons of the 3 measurements using the Friedman test

The median ox-LDL-Ab titers were high during the three samplings: 653.3 (468.2--838.8) mIU/ml at T1, 777.7 (553.7--1150.7) mIU/ml at T2, and 1037.7 (901.7--1481.5) mIU/ml at T3 (Table [1](#Tab1){ref-type="table"}). Around 56% of participants had a titer greater than 600 mIU/ml at T1, 72.2% at T2, and 88.9% at T3, with very high titers approaching 3000 mIU/ml. Ox-LDL-Ab values raised insignificantly from T1 to T2 (p = 0.122), but the increment was significant between T2 and T3 (p = 0.010) and between T1 and T3 (p = 0.006). The overall trend throughout the three measurements was a statistically significant increment: p = 0.006 (Tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"}; Fig. [1](#Fig1){ref-type="fig"}). Concomitantly, uric acid concentrations decreased significantly throughout the 3 samplings (median: 58.11 vs. 56.74 mg/l; p = 0.001), as well as FRAP titers (median 0.54 vs. 0.50 mmol/l; p = 0.003). On the contrary, GSH and SOD values increased (median 3.08 vs. 3.64 µmol/l and 17.25 vs. 21.25 IU/ml respectively), but non-significantly: p = 0.115 and p = 0.110 respectively (Tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"}).Fig. 1Variation of oxidized Low-Density-Lipoprotein antibodies (ox-LDL-Ab) titer between the three measurements. From T1 to T3, we observed a significant rise in oxidized LDL antibodies titers (p = 0.006)

There was a positive and significant correlation between ox-LDL-Ab and HDL-C, but only at the second sampling (ρ = 0.519, p = 0.027). There was also a positive and significant correlation between ox-LDL-Ab and SOD at the second sampling (ρ = 0.504, p = 0.033). The other correlations between ox-LDL-Ab and antioxidants were found very weak and statistically non-significant (Table [3](#Tab3){ref-type="table"}).Table 3Correlations between oxidized LDL antibodies (ox-LDL-Ab) and the other parameters at the three samplings (T1, T2 and T3)SamplingCorrelation between ox-LDL-Ab andCoefficient of correlation (ρ)p valueT1Total cholesterol0.3160.201Triglycerides−0.1380.586HDL0.0260.919LDL0.3680.133Uric acid0.0470.855FRAP−0.4130.089GSH0.2410.336SOD0.1360.591T2Total cholesterol0.1970.434Triglycerides−0.1150.650HDL*0.5190.027* **\***LDL−0.1460.564Uric acid−0.0940.711FRAP0.2770.266GSH0.1640.515SOD*0.5040.033* **\***T3Total cholesterol−0.2180.385Triglycerides0.0030.990HDL0.0850.738LDL−0.2500.317Uric acid−0.1230.627FRAP−0.2120.399GSH0.1000.692SOD0.0850.738\* p value \<0.05

Table [4](#Tab4){ref-type="table"} depicts the results of the regression analysis. All the coefficients of correlation were less than 0.566, reflecting an absence of strong correlation between the explanatory variables in the model. Two variables were significantly associated with ox-LDL-Ab: visit and SOD. The significance of the variable "visit" reflects a time effect: at each new visit, it is expected on average a 201.1 mIU/ml increase in ox-LDL-Ab levels (p = 0.041). Likewise, ox-LDL-Ab titers are expected to rise by 23.6 mIU/ml with each SOD increment of 1 IU/ml (p = 0.019). The coefficient of correlation between random slope and intercept was −0.92, and the AIC of this final model was 701.66.Table 4Results of the mixed linear regression model analysis with oxidized low-density lipoproteins (ox-LDL-Ab) as the dependent variableVariableValue (β)Standard errorp valueVisit*201.0993.860.0413*\*Uric acid7.534.470.1037HDL714.81478.780.1470LDL377.35312.030.2370Triglycerides−38.55322.160.9056FRAP129.60608.490.8329GSH59.4940.860.1569SOD*23.639.470.0191*\*Age26.4121.860.2445\* p \< 0.05

Discussion {#Sec9}
==========

Results from the present study show that titers of ox-LDL-Ab are very high in most of our players, with a significant increment over time as the competition is evolving. It seems therefore justified to infer that these high titers could be accounted for by a higher in vivo susceptibility of LDL-C to structural modification under conditions of intensive training-induced oxidative stress. Furthermore, of the 4 antioxidants measured, only SOD values could impact that of ox-LDL-Ab, and there were no or very weak correlations between ox-LDL-Ab and these antioxidants throughout the samplings. Consequently, the over-production of ox-LDL, inferred from that of ox-LDL-Ab, may not be efficiently counterbalanced by the antioxidant defense mechanism, which may lead thereby to lipid peroxidation and cell damage.

High levels of TG and low levels of HDL-C are among the elements shaping atherogenic dyslipidemia (AD); along with elevated levels of LDL-C, they are recognized as independent risk factors for cardiovascular disease (CVD) \[[@CR20]\]. There is body of evidence bolstering that regular physical training is associated with lowering of plasma total TG, total cholesterol and LDL-C concentrations, and an increase in HDL-C titers \[[@CR7]\], hence the prevention or retardation of AD, and CVD as well. We found for instance low levels of total cholesterol, LDL-C, and TG, and high levels of HDL-C among our players and throughout the different samplings, concurring previous reports \[[@CR7], [@CR21]\]. However, we observed a significant increment in levels of total cholesterol and LDL-C, a non-significant increase in TG concentrations, and an insignificant diminution in HDL-C titers over time, though their median values remained under normal ranges. As we did not compare our players to healthy sedentary individuals, and did not assess their nutritional profile, it is therefore difficult to have a clear explanation of this finding. The need to undertake a well-designed study in order to thoroughly assess this issue is thereby warranted.

Concurring with previous reports \[[@CR2], [@CR14], [@CR17], [@CR18], [@CR22]\], we observed high titers of ox-LDL-Ab as well as an increment in these titers over time. For instance, Pincemail et al. \[[@CR17]\] found very high titers of ox-LDL-Ab among half of their athletes, and Shippinger et al. \[[@CR18]\] observed an increase in ox-LDL-Ab at the mid-competition time point, though the values levelled off thereafter. On the contrary, other studies revealed a significant reduction in the oxidation of LDL-C after physical activity \[[@CR21], [@CR23]\], but these studies were undertaken in non-athletes. Our findings do suggest the presence of in vivo LDL-C oxidation processes during chronic exhaustive exercise.

Ox-LDL particles have atherogenic properties, and elevated levels of circulating ox-LDL have been reported to predict future cardiovascular events \[[@CR23], [@CR24]\]. Indeed, a large number of epidemiological and clinical studies indicate that increased titers of ox-LDL-Ab correlated with the progression and intensity of atherosclerosis \[[@CR25]\], hypertension \[[@CR4]\], and the appearance of coronary artery diseases \[[@CR26]\]. Ox-LDL-Ab have been found positively correlated with the degree of carotid stenosis in patients undergoing endarterectomy \[[@CR27]\], and the ox-LDL/LDL-C ratio was significantly associated with the coronary artery calcification score in hemodialysis patients \[[@CR28]\]. There is therefore an apparent paradox between the benefits of heavy aerobic exercise on cardiovascular risk factors and the potentially deleterious consequences of free radicals generated during heavy exercise. According to such observation, we can hypothesize that atherosclerotic diseases in professional athletes cannot be excluded during or at the end of their careers as it has been shown that atherogenic and cardiovascular risks are plausible in these categories of top athletes.

While examining the antioxidant response to the production of pro-oxidants (herein ox-LDL-Ab), we intriguingly noticed that apart from SOD levels which increased over time and impacted ox-LDL-Ab variation (β = 23.6; p = 0.019), GSH, FRAP and uric acid values decreased. Furthermore, there were no or very weak correlations between ox-LDL-Ab and other antioxidants at the different samplings. These findings suggest that the production of pro-oxidants among our soccer players may not be efficiently counterbalanced by the anti-oxidant defense mechanisms. Mirroring our results, Lehki et al. \[[@CR13]\] observed that alterations in the activities of SOD and higher level of non-enzymatic defenses in trained subjects may not be sufficient enough to counteract the increase in ROS produced by endurance training. By contrast, Brites et al. \[[@CR29]\] and Liu et al. \[[@CR14]\] showed that the increased production of pro-oxidants was accompanied by an adaptive response of antioxidants. These discrepancies may be explained by the different designs of these studies, the intensity of physical activity, and differences in diets.

Based on our results showing high levels of circulating ox-LDL-Ab insufficiently counteracted by antioxidant production among our athletes, it is likely that they may be exposed to lipid peroxidation and cell damage, hence an increased risk of atherosclerosis and CVD as well. In this context, supplementation of antioxidants could be beneficial in this setting. Indeed, appropriate nutrition is likely to be vitally important in maintaining adequate antioxidant defense mechanisms \[[@CR30]\]. There is convincing evidence that vitamin C & E supplementation have decreased LDL-C susceptibility to oxidation after exercise, though they did not enhance performance \[[@CR15], [@CR30]--[@CR32]\]. Furthermore, Ibero-Baraibar et al. \[[@CR33]\] demonstrated that the consumption of cocoa extract as part of ready-to-eat meals and within a hypo-caloric diet significantly decreased ox-LDL levels in middle-aged subjects, these effects being more beneficial in men. Contrariwise, some authors have found that, except for carbohydrate beverages, none of the commonly-used supplements are an effective countermeasure to exercise-induced immune suppression \[[@CR34], [@CR35]\]. Additionally, strong measures should be put in place to promote the adoption of healthy diets among our players. Moreover, further studies are needed, especially in SSA athletes, to better assess the cost-benefit profile of supplementation with exogenous antioxidants.

Unfortunately, the absence of a control group composed of healthy sedentary subjects precluded us from comparing and contrasting results that would have been obtained from the two groups. As a consequence, we are unable to conclude with strong evidence that changes observed with regard to pro- and antioxidant substances measured over time are only accounted for by chronic exposure to strenuous exercise. Further well-designed studies with more subjects are warranted to better elucidate the effect of chronic exhaustive training on oxidative stress status of professional SSA athletes. Additionally, we did not investigate the nutritional profile of our participants which could have explained some of our results, notably the variations in uric acid levels, even though the players' kidney function was normal \[[@CR36]\]. Another flaw of this study lies in the small number of participants rending difficult the application of the mixed linear regression model. Nonetheless, we applied the restricted maximum likelihood method which is well suited for small samples. On the other hand and in order to better assess the antioxidant defense mechanism of our participants, we measured 4 related markers in line with the recommendations stating that at least two techniques should be used for an accurate and consistent evaluation of oxidative stress in humans \[[@CR37]\]. Moreover, there are few studies that have followed-up professional athletes during part of a competition to seek for modifications of their oxidative status over time, and to the best of our knowledge, this is one of the rare studies conducted in SSA and dedicated to this question.

Conclusion {#Sec10}
==========

This study showed that in a context of chronic strenuous exercise, Cameroonian professional soccer players exhibit high levels of ox-LDL-Ab with an increment in these titers over time, this being insufficiently counterbalanced by their antioxidant defense mechanisms. As a consequence, atherogenic and cardiovascular risks are plausible in these categories of top athletes. Therefore, indices of oxidative stress as well as the antioxidant capacity should be monitored in this population. Additionally, bolstering athletes' antioxidant defenses with exogenous antioxidant supplements may ameliorate exercise-induced damage (LDL-C oxidation), hence avoiding lipid peroxidation and tissue damage, but this must be underpinned by local robust evidence. Further studies are warranted, which will assess the global risk of atherosclerosis among our top athletes, including all its known risk factors.
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